Dr. David A Resnick, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 200 E Main St, Ada, MN 56510 Phone: 218-784-7119 Fax: 218-784-2381 |
Alex Provo Dentist Medicare: Not Enrolled in Medicare Practice Location: 200 E Main St, Ada, MN 56510 Phone: 218-784-7119 |
Dr. Debra A Ettle, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 200 E Main St, Ada, MN 56510 Phone: 218-784-7119 Fax: 218-784-2381 |
News Archive
NewsMed speaks to KNAUER about the company's background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010.
AstraZeneca today announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC).
NeoTract, Inc. a medical device company focused on developing urology devices, today announced that the first U.S. patients have been enrolled in a multinational trial of its UroLift® System at Western Urological Clinic in Salt Lake City, Utah.
A group of researchers from the university's School of Science, led by Dr Solomon Habtemariam, believe they have identified potential sources of medicines derived from plants which may have fewer adverse side-effects for diabetes sufferers.
› Verified 8 days ago